Healthcare Triangle Secures $1.63 Million Through Warrant Exercise Agreements

Healthcare Triangle, Inc. (Nasdaq: HCTI) has entered into warrant exercise agreements with three existing accredited investors to exercise outstanding warrants for approximately $1.63 million in gross proceeds. The transaction involves the immediate exercise of 812,775 existing warrants at a reduced price of $2.00 per share, down from the original $20.92 exercise price, providing immediate capital infusion for the digital healthcare solutions provider.

In exchange for exercising their existing warrants, the investors will receive new warrants to purchase up to 812,775 additional shares of common stock at $3.00 per share. These new warrants become exercisable once stockholder approval is obtained and will remain valid for five years from that approval date. The transaction, expected to close on October 2, 2025, represents a strategic move to strengthen the company's financial position while maintaining investor participation through the new warrant structure.

The significance of this funding extends beyond the immediate capital raise. For Healthcare Triangle, which specializes in digital transformation solutions for healthcare organizations, hospitals, health systems, payers, and pharmaceutical companies, this infusion comes at a critical time when healthcare technology adoption is accelerating globally. The company's achievement of HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™, demonstrates its commitment to maintaining the highest standards for data protection and information security in the highly regulated healthcare sector.

This financial maneuver allows Healthcare Triangle to continue supporting healthcare organizations in their digital transformation journeys while addressing immediate business needs and competitive threats. The healthcare technology sector has seen increased demand for cloud solutions, security compliance, and data lifecycle management services, particularly as organizations seek to improve health outcomes through better utilization of data and information technologies. The warrant inducement strategy provides the company with working capital to pursue growth opportunities without the immediate dilution concerns associated with traditional equity offerings.

WallachBeth Capital is serving as the sole placement agent for the warrant inducement transaction, bringing expertise in structuring such financial arrangements. The transaction structure, involving the exchange of existing warrants for new ones at different exercise prices, represents a sophisticated approach to corporate financing that balances immediate capital needs with long-term investor alignment. This funding approach may signal a trend in how healthcare technology companies are navigating current market conditions while positioning for future growth in the rapidly evolving digital healthcare landscape.